CinQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo

Dong Joon Kim, Mee Hyun Lee, Srinivasa Reddy Kanamata Reddy, Yani Li, Do Young Lim, Hua Xie, Sung-Young Lee, Young Il Yeom, Ann M. Bode, Zigang Dong

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The mitogen-activated protein kinase kinase 1 and 2 signaling pathway is a major component of the RAS (Rat sarcoma)/RAF (Radpidly accelerated fibrosarcoma)/MEK (mitogen-activated protein kinase kinase)/ERKs (Extracellular signal-regulated kinases) signaling axis that regulates tumorigenesis and cancer cell growth. MEK is frequently activated in various cancers that have mutations in the KRAS and BRAF oncogenes. Therefore, MEK has been suggested as a therapeutic target for inhibitor development against tumors that are dependent on the activating mutations in mitogen-activated protein kinase signaling. Herein, we report the discovery of three novel MEK inhibitors, herein referred to as CInQ-01, CInQ-03 and CInQ-06. All three inhibitors were highly effective in suppressing MEK1 and MEK2 in vitro kinase activity as well as anchorage-dependent and anchorage-independent cell growth. The inhibitory activity was associated with markedly reduced phosphorylation of ERKs and ribosomal S6 kinases. Furthermore, administration of CInQ-03 inhibited colon cancer cell growth in an in vivo xenograft mouse model and showed no skin toxicity. Overall, these results suggest that these novel MEK inhibitors might be used for chemotherapy or prevention.

Original languageEnglish (US)
Pages (from-to)1134-1143
Number of pages10
Issue number5
StatePublished - May 2013

Bibliographical note

Funding Information:
The Hormel Foundation and National Institutes of Health grants CA120388, CA027502, R37CA081064 and ES016548 and the Korea Research Council of Fundamental Science and Technology (KRCF) Research Fellowship for Young Scientists.


Dive into the research topics of 'CinQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo'. Together they form a unique fingerprint.

Cite this